|
Mastectomy
|
E04.466 |
|
|
Aminophylline
|
D03.633.100.759.758.824.751.075 |
|
|
Theophylline
|
D03.633.100.759.758.824.751 |
|
|
Advanced Trauma Life Support Care
|
E02.760.440.040 |
|
|
Calcium Channel Agonists
|
D27.505.954.411.793.205 |
|
|
Vasoconstrictor Agents
|
D27.505.954.411.793 |
|
|
Transcription Factor CHOP
|
D12.776.930.127.124.875 |
|
|
Diagnostic Screening Programs
|
D000076862 |
[Services for the presumptive identification of unrecognized disease in an apparently healthy, asymptomatic population by means of tests, examinations or other procedures that can be applied rapidly and easily to the target population. (from World Health Organization http://www.who.int/cancer/prevention/diagnosis-screening/screening/en/ Oct. 24,2017)
] |
|
Locked-In Syndrome
|
C23.888.592.636.786.500 |
|
|
Quadriplegia
|
C23.888.592.636.786 |
|
|
Minichromosome Maintenance Complex Component 6
|
D12.776.664.235.750.600 |
|
|
Hemianopsia
|
C10.597.751.941.512 |
|
|
Space Perception
|
F02.463.593.778 |
|
|
Extracellular Fluid
|
A11.284.295.260 |
|
|
Clostridium botulinum type E
|
B03.353.625.375.500.160.250 |
|
|
Cerium Radioisotopes
|
D01.496.749.185 |
|
|
Colloids
|
D26.255.165 |
|
|
Dosage Forms
|
D26.255 |
|
|
Amacrine Cells
|
A08.675.358.050 |
|
|
MAP Kinase Kinase 3
|
D08.811.913.696.620.682.700.565.300 |
|
